EMERALD ADVISERS, LLC - TURNING POINT THERAPEUTICS I ownership

TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 191 filers reported holding TURNING POINT THERAPEUTICS I in Q3 2021. The put-call ratio across all filers is 1.80 and the average weighting 0.1%.

Quarter-by-quarter ownership
EMERALD ADVISERS, LLC ownership history of TURNING POINT THERAPEUTICS I
ValueSharesWeighting
Q3 2021$7,705,000
-15.0%
115,983
-0.2%
0.28%
-15.2%
Q2 2021$9,070,000
-46.9%
116,251
-35.6%
0.33%
-46.4%
Q1 2021$17,074,000
-60.8%
180,508
-49.4%
0.62%
-57.3%
Q4 2020$43,505,000
+66.6%
357,038
+19.4%
1.44%
+34.3%
Q3 2020$26,121,000
+88.7%
299,008
+39.5%
1.08%
+78.3%
Q2 2020$13,842,000
+291.5%
214,309
+170.7%
0.60%
+194.1%
Q1 2020$3,536,00079,1800.20%
Other shareholders
TURNING POINT THERAPEUTICS I shareholders Q3 2021
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 2,392,297$291,501,0006.94%
Burrage Capital Management LLC 72,484$8,832,0006.73%
MPM BioImpact LLC 617,372$75,226,0006.50%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 113,541$13,816,0003.77%
Orbimed Advisors 2,745,327$334,518,0002.93%
SECTORAL ASSET MANAGEMENT INC 257,379$31,362,0002.21%
Parkman Healthcare Partners LLC 59,377$7,235,0001.85%
Nicholas Investment Partners, LP 183,676$22,381,0001.73%
EMERALD ADVISERS, LLC 357,038$43,505,0001.44%
EMERALD MUTUAL FUND ADVISERS TRUST 336,173$40,963,0001.42%
View complete list of TURNING POINT THERAPEUTICS I shareholders